Nitromed Report issue

For profit Phase 4
Founded: Bedford MA United States (1987)
Status: Defunct (2009)

Organization Overview

First Clinical Trial
2001
NCT00047775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

hydralazine (apresoline) (1 trial)

isosorbide (isordil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2